These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15221283)

  • 41. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
    Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
    Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
    Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M
    Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T; Lai WK; Mutimer D
    Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the antigenemia assay and screening bronchoscopy for detection of cytomegalovirus infection after bone marrow transplantation.
    Machida U; Kami M; Kanda Y; Mori S; Ohashi K; Tanikawa S; Akiyama H; Sakamaki H
    Bone Marrow Transplant; 1999 Nov; 24(10):1153-4. PubMed ID: 10578168
    [No Abstract]   [Full Text] [Related]  

  • 45. Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation.
    Takami A; Shibayama M; Orito M; Omote M; Okumura H; Yamashita T; Shimadoi S; Yoshida T; Nakao S; Asakura H
    Bone Marrow Transplant; 2007 Apr; 39(8):501-7. PubMed ID: 17334382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary excretion of ganciclovir contributes to improvement of adenovirus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation.
    Nakazawa Y; Suzuki T; Fukuyama T; Katsuyama Y; Tanaka M; Yanagisawa R; Sakashita K; Shiohara M; Koike K
    Pediatr Transplant; 2009 Aug; 13(5):632-5. PubMed ID: 18992066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Incidence, therapy and prevention of cytomegalovirus disease after bone marrow transplantation].
    Schuler U; Ehninger G
    Med Klin (Munich); 1992 Oct; 87 Suppl 1():30-8. PubMed ID: 1334220
    [No Abstract]   [Full Text] [Related]  

  • 50. Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir.
    Openshaw H; Slatkin NE; Smith E
    Bone Marrow Transplant; 1997 Mar; 19(5):503-5. PubMed ID: 9052919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen.
    Thomas LD; Milstone AP; Miller GG; Loyd JE; Stephen Dummer J
    Clin Transplant; 2009; 23(4):476-83. PubMed ID: 19453645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program.
    Rossini F; Terruzzi E; Cammarota S; Morini F; Fumagalli M; Verga L; Elli E; Verga M; Miccolis I; Parma M; Pogliani EM
    Transpl Infect Dis; 2005; 7(3-4):122-5. PubMed ID: 16390400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).
    Cornetta K; Laughlin M; Carter S; Wall D; Weinthal J; Delaney C; Wagner J; Sweetman R; McCarthy P; Chao N
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):149-60. PubMed ID: 15682076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of residual leukocyte subsets with neutropenic fever during severe leukopenia after high-dose chemotherapy and autologous stem cell transplantation.
    Schnabel B; Schmidmaier R; Franke D; Emmerich B; Straka C
    Cytotherapy; 2006; 8(5):473-9. PubMed ID: 17050252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients.
    Laws HJ; Kobbe G; Dilloo D; Dettenkofer M; Meisel R; Geisel R; Haas R; Göbel U; Schulze-Röbbecke R
    J Hosp Infect; 2006 Jan; 62(1):80-8. PubMed ID: 16242206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
    Oza A; Hallemeier C; Goodnough L; Khoury H; Shenoy S; Devine S; Augustin K; Vij R; Trinkaus K; Dipersio JF; Adkins D
    Transfusion; 2006 Jan; 46(1):14-23. PubMed ID: 16398726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aciclovir or ganciclovir universal prophylaxis of cytomegalovirus infection in liver transplantation: an economic analysis.
    Leong RW; Smith DW; Garas G; Beaman JM; Mitchell AW; Heath DI; House AK; Jeffrey GP
    Intern Med J; 2004 Jul; 34(7):410-5. PubMed ID: 15271175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.